MingMed
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at MingMed
Crystal Hung
Vice President of Finance
About MingMed
We are an innovative biopharmaceutical company dedicated to the discovery, development and commercialization of novel drugs for global unmet medical needs. Guided by our mission – “To explore the cause of disease and deliver better medicines for humanity (知因，明醫，為人), we leverage our integrated R&D and operational excellence to built and advance a synergistic portfolio. Our core focus spans ophthalmic drugs, recombinant botulinum toxin, immuno-oncology drugs and companion animal medicines, all developed in-house. With strong translation capability - from early discovery to commercialization - we are committed to delivering first-in-class treatments that make a meaningful difference in patients' lives.
MingMed revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
MingMed has never raised funding before.
United Kingdom
Canada
United States
Korea, Republic of
Australia
Frequently asked questions
4.8
40,000 users
